GIP/GLP-1

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
43:25

Dimitris Papamargaritis

New Treatments for Obesity

  • 2,683 views
  • March 7, 2023
  • 8
44:30

Jefferson Health

Diabesity: New Trends in Management

FEATURING Kevin Furlong
  • 846 views
  • November 23, 2023
  • 11
49:21

McMaster University Department of Medicine

Semaglutide: Where Are We Now and Where Are We Going?

FEATURING Shamma Boushahri, Daniel Lazzam, Kelsey MacEachern
  • 4,228 views
  • September 27, 2023
  • 26
19:31

Daniel Weghuber

Advancements in the Management of Obesity in Adolescents

  • 825 views
  • June 19, 2023
  • 3
13:35

AHA 2023 Insights

AHA 2023 Insights: Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity and Cardiovascular Disease Who Do Not Have Diabetes - The SELECT Trial

FEATURING A. Michael Lincoff
  • 1,440 views
  • November 20, 2023
  • 5
11:24

Francesco Giorgino

2021 ADA Highlights: SURPASS Program: Change in HbA1C From Baseline

  • 906 views
  • July 14, 2021
  • 4
34:11

Houston Methodist Hospital

Obesity: Epidemiology and Medical Management in 2023

FEATURING Archana Sadhu
  • 1,374 views
  • August 22, 2023
  • 6
10:07

Houston Methodist DeBakey Heart and Vascular Center

Should Cardiometabolic Protective Agents be the First Choice for Diabetic Patients?

FEATURING Kershaw Patel
  • 1,913 views
  • November 15, 2022
  • 8
36:07

Duke Health

Diabetes Updates

FEATURING Tracy Setji
  • 672 views
  • August 16, 2024
  • 5
42:15

Primary Care Education Consortium

Cardiovascular and Kidney Outcomes With Glucose-Lowering Agents

FEATURING James Gavin Iii
  • 989 views
  • November 21, 2023
  • 8
06:02

Susan Brian

Brain Benefits of GLP-1s

  • 26 views
  • May 9, 2024
04:03

Susan Brian

New Research: Side Effect of GLP1

  • 1,082 views
  • May 9, 2024
  • 14
39:32

Michigan Medicine

Type 2 Diabetes - Medical Management

FEATURING Amy E. Rothberg
  • 183 views
  • August 28, 2024
  • 5
28:02

Barbara Mcgowan

Obesity in the Year 2024

  • 1,387 views
  • April 12, 2024
  • 9
19:37

Norbert Stefan

EASD Insights: SGLT2 Inhibitors and GLP-1 Receptor Agonist and the Liver - Mechanisms of Beneficial Action Beyond Glycaemic Control

  • 820 views
  • October 26, 2023
  • 4
31:06

MUSC Cardiology

When Lifestyle Alone Misses the Mark: Pharmacological Advances for Management of Obesity

FEATURING Marc-André Cornier
  • 1,104 views
  • March 29, 2024
  • 8
55:24

Primary Care Education Consortium

Treatment Approaches for Obesity: Pharmacologic

FEATURING Robert Kushner
  • 1,965 views
  • February 27, 2024
  • 10
59:30

Scripps Health

Primary Care Literature Update: 2022/2023

FEATURING Joel Diamant
  • 1,019 views
  • September 12, 2023
  • 18
07:28

Susan Brian

SURMOUNT 2: Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes

  • 861 views
  • April 26, 2024
  • 5
13:43

Stanford Medicine

What's the Ideal Therapy for Obesity?

FEATURING Aaron Yeoh
  • 3,639 views
  • June 13, 2023
  • 21
20:17

AHA 2023 Insights

AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit

FEATURING Faiez Zannad
  • 1,760 views
  • November 21, 2023
  • 19
36:16

Keck School of Medicine of USC

Should Obesity Be the Treatment Target in Type 2 Diabetes?

FEATURING Jaime Almandoz
  • 502 views
  • November 30, 2023
  • 4
42:39

Primary Care Education Consortium

A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 3

FEATURING James Gavin Iii
  • 655 views
  • November 30, 2023
  • 10
16:25

The North American Thrombosis Forum (NATF)

An Internist's Perspective: Understanding Obesity and it's Management

FEATURING Judy Shiau
  • 792 views
  • May 16, 2023
  • 5
47:29

Alyson Myers

Closing the Disparity Gaps in Diabetes Care - in the Bronx and Beyond

  • 133 views
  • August 18, 2023
  • 2

GIP/GLP-1

All Topics: